Systematic Financial Management LP Sells 68,967 Shares of Perrigo Company plc $PRGO

Systematic Financial Management LP trimmed its position in Perrigo Company plc (NYSE:PRGO) by 5.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,260,959 shares of the company’s stock after selling 68,967 shares during the period. Systematic Financial Management LP owned 0.92% of Perrigo worth $17,553,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of PRGO. Vanguard Group Inc. lifted its stake in shares of Perrigo by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after acquiring an additional 1,101,154 shares during the last quarter. Ion Asset Management Ltd. lifted its stake in shares of Perrigo by 34.7% in the 2nd quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after acquiring an additional 983,727 shares during the last quarter. Diamond Hill Capital Management Inc. raised its position in Perrigo by 38.0% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 2,481,711 shares of the company’s stock worth $34,545,000 after purchasing an additional 683,965 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Perrigo by 126.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock worth $32,520,000 after purchasing an additional 647,982 shares during the last quarter. Finally, State Street Corp raised its position in Perrigo by 9.5% during the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after purchasing an additional 637,678 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors.

Perrigo Stock Performance

PRGO stock opened at $11.21 on Friday. The stock has a 50-day moving average price of $10.83 and a 200-day moving average price of $12.84. Perrigo Company plc has a 1-year low of $9.23 and a 1-year high of $28.43. The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45. The firm has a market cap of $1.55 billion, a PE ratio of -0.86, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.04. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The firm had revenue of $841.80 million during the quarter, compared to analyst estimates of $1.04 billion. During the same period last year, the company posted $0.60 EPS. The business’s quarterly revenue was down 7.2% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities research analysts expect that Perrigo Company plc will post 2.14 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Friday, May 29th will be given a $0.29 dividend. The ex-dividend date of this dividend is Friday, May 29th. This represents a $1.16 annualized dividend and a dividend yield of 10.4%. Perrigo’s dividend payout ratio (DPR) is -8.85%.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 13th. Canaccord Genuity Group lowered their target price on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research report on Friday, February 27th. Finally, Jefferies Financial Group reaffirmed a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Perrigo presently has an average rating of “Hold” and an average price target of $19.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.